Delta Air Lines [DAL] - Last Close: $30.38
Delta is trending after releasing its earnings report yesterday.
On Thursday, Delta missed analyst's targets for both earnings and revenues, but comments from the CEO sent shares higher regardless.
CEO Ed Bastion said sales have remained strong into Sept., and he sees nothing that makes him think "that this momentum won't continue."
Delta generated adjusted EPS of $1.51 for Q3 and revenues of $14.0 billion, which slightly missed analysts estimates.
DAL made solid gains on Thursday, and it's leading the S&P 500 with a 2.9% gain on active trading volume.
My Take: The airline industry sounds like it's in decent shape, despite soaring ticket prices and labor issues. Nonetheless, it's always tough to pick winners in this highly competitive industry.
Imara Inc [IMRA] - Last Close: $2.58
A merger announcement is lifting shares of Imara Inc in today's premarket.
Late Thursday, the clinical-stage biopharma firm announced it will merge with Enliven Therapeutics in an all-stock deal.
The combined company is expected to have $300 million in cash and cash equivalents upon closing, and it will prioritize advancing Enliven's pipeline.
The newly-formed company will operate under the name Enliven Therapeutics, and it's shares will trade on the Nasdaq Global Select Market under the ticker symbol ELVN.
IMRA is on of this morning's most active stocks, and it's up 29.8% on the news.
My Take: Enliven has a promising drug pipeline, so the merger instantly made IMRA more valuable. Share prices have been trending sideways since Sept., but this could be the catalyst it needs to break out.
Laser Photonics Corp [LASE] - Last Close: $4.13
Laser Photonics is on our list for a third time this week, with more gains in today's premarket.
The industrial laser-maker was already running red-hot after landing deals with two major institutions this week, the US Navy and Coca-Cola [KO].
Today, Laser Photonics announced it's launching an aggressive hiring campaign in response to the sharp increase in sales leads and inquiries.
The company also said it plans to invest in marketing, operations, and engineering to drive growth.
LASE up 26.6%, and it's one of this morning's highest-volume trades.
My Take: This might be the first time that a stock has been on our list three times in a week. LASE is absolutely on fire, but this rally can't last forever.
If you like this stock, sorry to say, you're late to the party. You might be better off waiting for a pullback before you dive into this one.
EarGo [EAR] - Last Close: $0.71
EarGo is up on the heels of a regulatory filing.
The hearing-focused medical device company filed Form FWP to set the record date for a proposed rights offering at Oct. 24th.
On that date, existing EAR shareholders will have the opportunity to purchase more shares of the stock.
EarGo intends to raise up to $187.5 million in aggregate gross proceeds from the rights offering, which the company first proposed on Aug. 25th.
The Company expects to use a substantial portion of the proceeds from the proposed Rights Offering to repay the outstanding notes issued to Patient Square Capital at a premium.
EAR shot to a 16.5% gain on the news, but it gave back some of its gains. The stock is currently up 8.5% on active trading volume.
My Take: Investors seem to support EAR's plan to pay off some of its debts through a rights offering. However, the stock's chart is pretty ugly, and I'm worried it could see a big pullback next week.
